(A) Ndufa9 mRNA levels (relative to β2-microglobulin; normalized) in isolated hepatocytes of the indicated genotype, assessed by qRT-PCR. n=3 animals per group. The same color scheme is used …
Full gel images for Figure 1.
Full gel images and original image files for western blots in Figure 1.
(A) Oxygen consumption rates in Ndufa9f/f and Ndufa9-/- mouse embryonic fibroblasts (MEFs). n=22–24 wells per group. The same color scheme is used throughout this figure. (B) Normalized NAD+ / NADH …
(A) Representative histology (H&E, Oil Red O, PAS staining) images of liver cross sections from animals of the indicated genotype at 2 weeks post-AAV administration. Scale bar: 50 μm. (B) Liver …
(A) Representative histology (H&E, Oil Red O, PAS staining) images of liver cross-sections from animals of the indicated genotype at eight weeks post-AAV administration. Scale bar: 50 μm. (B) …
(A) ATP levels from livers of the indicated genotype. n=3 mice per group. The same color scheme is used throughout this figure. (B) Reduced glutathione to oxidized glutathione ratio (GSH/GSSG) in …
Full gel images for Figure 2.
Full gel images and original image files for western blots in Figure 2.
(A) Volcano plot of protein abundances changes in Ndufa9-/- vs. Ndufa9f/f livers, based on proteomics analysis of enriched mitochondria. Mitochondrial proteins (based on MitoCarta 3.0) are shown. …
Representative immunofluorescent images of liver sections at 20 x (left; scale bar 50 μm) and 63 x (right; scale bar 5 μm) of the indicated genotype. TOMM20 (mitochondrial) staining is indicated in …
(A) Schematic of potential fates of glucose and lactate within central carbon metabolism. Carbon atoms are indicated with circles for each compound. G1P, glucose-1-phosphate; 3 PG, …
(A) Mass isotopomer distributions in liver tissue from [U-13C]glucose infusions in animals of the indicated genotype. n=3 animals per group; 4 weeks post-AAV administration. Statistical significance …
(A) Cox10 mRNA levels (relative to β2-microglobulin; normalized) in livers of the indicated genotype, assessed by qRT-PCR at 4 weeks post-AAV administration. n=4–5 animals per group. The same color …
Full gel images for Figure 4.
Full gel images and original image files for western blots in Figure 4.
(A) Mass isotopomer distributions related to lactate/pyruvate tolerance test (Figure 4H, I), for plasma lactate and glucose. n=4–5 mice per group; 8 weeks post-AAV administration. Numerical data for …
(A) ATP levels in livers of the indicated genotype. n=3 animals per group. The same color scheme is used throughout this figure. (B) Reduced glutathione to oxidized glutathione ratio (GSH:GSSG) in …
Full gel images for Figure 5.
Full gel images and original image files for western blots in Figure 5.
(A) Significantly enriched biological pathways (FDR <0.05) from gene ontology analysis of all upregulated proteins (log2(fold change)>1; p-value <0.05) in Cox10-/- livers, based on proteomic …
(A) Significantly enriched biological pathways (FDR <0.05) from gene ontology analysis of all downregulated proteins (log2(fold change) < –1; p-value <0.05) in Cox10-/- livers, based on proteomic …
(A) Volcano plot of protein abundances changes in Cox10-/- vs. Cox10f/f livers, based on proteomics analysis of enriched mitochondria. Mitochondrial proteins (based on MitoCarta 3.0) are shown. Log2(…
(A) Relative abundance of cholate species in livers of the indicated genotype. n=4–6 mice per group; 8 weeks post-AAV administration. (B) Relative abundance of electron acceptors/donors from livers …
(A) Left, volcano plot of identified proteins from the Fatty Acid Synthesis (GO:0006633) pathway, based on proteomics performed on Cox10-/- vs. Cox10f/f livers at 8 weeks post-AAV administration. …
(A) Left, volcano plot of identified proteins from the Bile Acid Metabolic Process (GO:0008206) pathway, based on proteomics performed on Cox10-/- vs. Cox10f/f livers at 8 weeks post-AAV …
(A) Left, volcano plot of identified proteins from the Oxidoreductase (GO:0016491) pathway, based on proteomics performed on Cox10-/- vs. Cox10f/f livers at 8 weeks post-AAV administration. …
Representative immunofluorescent images of liver sections at 20 x (left; scale bar 50 μm) and 63 x (right; scale bar 5 μm) of the indicated genotype. TOMM20 (mitochondrial) staining is indicated in …
(A) Perfusion values (reported as institutional units (I.U.)) based on arterial spin labeling in animals of the indicated genotype at 4 weeks post-AAV administration. n=3 animals per group. The same …
(A) Mass isotopomer distributions in liver tissue from [U-13C]glucose infusions of the indicated genotype. n=3 animals per group; 4 weeks post-AAV administration. Statistical significance was …
(A) BN-PAGE, followed by Coomassie staining, of isolated mitochondria extracted with 5g/g digitonin/protein ratio. 50mg of protein per lane were assessed by BN-PAGE, and bands are annotated based on …
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus, male and female) | Cox10f/f | The Jackson Laboratory | 024697 | |
Strain, strain background (Mus musculus, male and female) | Ndufa9f/f | |||
Other | pAAV.TBG.PI.eGFP. WPRE.bGH (AAV-GFP) | Addgene | 105535 | Adeno-associated virus |
Other | pAAV.TBG.PI.Cre. rBG (AAV-Cre) | Addgene | 107787 | Adeno-associated virus |
Antibody | Anti-Tom20 (rabbit polyclonal) | Proteintech | 11802 | WB, 1:2000 |
Antibody | Anti-PC (rabbit polyclonal) | Proteintech | 16588 | WB, 1:1000 |
Antibody | Anti-βActin (mouse monoclonal) | Proteintech | 66009 | WB, 1:5000 |
Antibody | Anti-Ndufa9 (mouse monoclonal) | ThermoScientific | 459100 | WB, 1:2000 |
Antibody | Anti-β2microglobulin (rabbit monoclonal) | ThermoScientific | 701250 | WB,:5000 |
Antibody | Anti-Cox10 (rabbit polyclonal) | Abcam | ab84053 | WB,:1000 |
Commercial assay or kit | Complex I Enzyme Activity Microplate Assay Kit (Colorimetric) | Abcam | ab109721 | |
Commercial assay or kit | ATP Colorimetric/ Fluorometric Assay Kit | Biovision | K354 | |
Commercial assay or kit | Deproteinizing Sample Preparation Kit | Biovision | K808 | |
Commercial assay or kit | Luna Universal One- Step RT-qPCR kit | New England Biolabs | E3005S | |
Commercial assay or kit | DC Protein Assay | Biorad | 5000112 | |
Chemical compound, drug | [U-13C]glucose | Cambridge Isotopes Laboratories | CLM-1396 | |
Chemical compound, drug | [U-13C]lactate | Cambridge Isotopes Laboratories | CLM-1579 | |
Chemical compound, drug | [U-13C]pyruvate | Cambridge Isotopes Laboratories | CLM-2440 |
Excel spreadsheet containing raw data and statistical analysis of proteomics and metabolomics data for Ndufa9-/- vs. Ndufa9f/f livers at 4 weeks post-AAV administration.
Excel spreadsheet containing raw data and statistical analysis of proteomics and metabolomics data for Cox10-/- vs. Cox10f/f livers at 8 weeks post-AAV administration.
Excel spreadsheet containing raw data for panels presented in the figures and figure supplements.